LEADER 01262nas  2200361-  450 
001 996409047103316
005 20230110155612.0
011   $a2689-4653
035   $a(OCoLC)1126008986
035   $a(CKB)4100000011528154
035   $a(CONSER)--2019203341
035   $a(DE-599)ZDB3053346-6
035   $a(EXLCZ)994100000011528154
100   $a20191101a20209999  ---            a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAndrogens $eclinical research and therapeutics
210  1$aNew Rochelle, NY :$cMary Ann Liebert, Inc.,$d2020-
300   $aRefereed/Peer-reviewed
330 2 $aPremier global open access journal for peer-reviewed science, research, and education regarding the effects of the presence, deficiency, and use of testosterone and other androgens in diverse patient populations and the influence of these hormones on multiple disease states and conditions.
531 0 $aAndrogens
606   $aAndrogens$3(DNLM)D000728
608   $aPeriodical
615  2$aAndrogens
676   $a612.61
712 02$aMary Ann Liebert, Inc.,
906   $aJOURNAL
912   $a996409047103316
996   $aAndrogens$92573501
997   $aUNISA